Manufacturing News of Note—Halix boosts viral vector production; FDA reassures patients taking blood pressure meds


Here is some news of note for the week: 

> Halix, a CDMO in the Netherlands, says it completed a five-level production facility for making viral vaccines and viral vectors as well as protein manufacturing at its site in Leiden. Release

> The FDA issued a statement to try to ease consumer concerns over the risks of contaminated sartan drugs. Statement

> The Novo Nordisk Foundation has awarded $27 million in grants to help the improve pharmaceutical processes to be easier on the environment. Release

> CDMO Sterling Pharma Solutions has started large-scale production of silica particles. Release

> Biocon says its insulin facility in Malaysia has been approved by the EU. Release

> Orano Med says it is investing €15 million in facilities in France and the U.S. to develop treatments using radioactive properties. Story

Suggested Articles

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.

AstraZeneca and Oxford BioMedica have inked a deal to produce commercial and clinical supply of the University of Oxford's COVID-19 shot hopeful.